Mustafa Bilgin Ali Djamgoz

This inventor holds 6 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Celex Oncology Innovations Ltd., Celex Oncology Limited, Imperial College Innovations Limited. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mustafa Bilgin Ali Djamgoz. Retrieved from https://idiyas.com/inventor/mustafa-bilgin-ali-djamgoz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 8)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

4 out of 4

Celex Oncology Innovations Ltd.

patents

1 out of 1

Celex Oncology Limited

patent

1 out of 174

Imperial College Innovations Limited

patents

Years Active: 2010-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624101 - MONOCLONAL ANTIBODIES AGAINST NEONATAL NAV1.5 (2026-05-12),

2. 12605390 - Treatment of cancer and inhibition of metastasis (2026-04-21),

3. 12534444 - Treatment of cancer/inhibition of metastasis (2026-01-27),

4. 12508260 - COMBINATION TREATMENTS (2025-12-30),

5. 11634398 - Treatment of cancer/inhibition of metastasis (2023-04-25),

6. 7759078 - Diagnosis and treatment of cancer (2010-07-20),

Profile summary based on public USPTO records.